ELTX
Elicio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.89
+1.34%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-53.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Nissenson Allen · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Ashe Carol Gail · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | ADAMS JULIAN · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Venkatesan Jay · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | WILSON KAREN J · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | RUFFOLO ROBERT R · director | A-Award | 21,750 | $2.70 |
| Jul 17, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 64,643 | $3.20 |
| Jul 17, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 186,944 | $3.20 |
| Jul 17, 2026 | Shah Preetam · officer: See Remarks | A-Award | 60,833 | $3.20 |
| Jul 17, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 52,832 | $3.20 |
| Feb 3, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 147,200 | $8.10 |
| Feb 3, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 73,600 | $0.00 |
| Feb 3, 2026 | Shah Preetam · officer: See Remarks | A-Award | 47,900 | $8.10 |
| Feb 3, 2026 | Shah Preetam · officer: See Remarks | A-Award | 24,000 | $0.00 |
| Feb 3, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 41,600 | $8.10 |
| Feb 3, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 20,800 | $0.00 |
| Feb 3, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 25,400 | $0.00 |
| Feb 3, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 50,900 | $8.10 |
| Dec 10, 2025 | DeMuth Peter · officer: Chief Scientific Officer | M-Exempt | 362 | $4.41 |
| Jun 4, 2025 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 103,225 | $7.75 |
| May 20, 2025 | RUFFOLO ROBERT R · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Ashe Carol Gail · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Nissenson Allen · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Venkatesan Jay · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | ADAMS JULIAN · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | WILSON KAREN J · director | A-Award | 7,900 | $5.84 |
| Apr 16, 2025 | Shah Preetam · officer: See Remarks | A-Award | 191,624 | $4.98 |
| Feb 4, 2025 | Haqq Christopher · officer: See Remarks | A-Award | 44,000 | $8.92 |
Institutional positioning
13F filings over the trailing two quarters
New 47Increased 30Reduced 11Sold out 22
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Knoll Capital Management, LLC | Increased | 1,211,957 | Sep 10, 2026 |
| BlackRock, Inc. | Increased | 766,005 | Aug 7, 2026 |
| KNOLL CAPITAL MANAGEMENT, LLC | Unchanged | 630,915 | May 15, 2026 |
| Caption Management, LLC | New Position | 583,800 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 572,151 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 518,638 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 373,804 | May 15, 2026 |
| Ikarian Capital, LLC | New Position | 314,200 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 311,354 | Aug 12, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 271,500 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 244,814 | May 15, 2026 |
| DIADEMA PARTNERS LP | New Position | 212,100 | Aug 14, 2026 |
| TORONTO DOMINION BANK | New Position | 200,000 | Aug 14, 2026 |
| JANE STREET GROUP, LLC | Increased | 186,000 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 179,420 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026